{"id":"W4238740123","doi":"10.4161/mabs.2.2.11271","title":"Certolizumab Pegol","year":2010,"lang":"it","type":"review","venue":"mAbs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Certolizumab pegol; Medicine; Rheumatoid arthritis; Monoclonal antibody; Infliximab; Arthritis; Internal medicine; Adalimumab; Tumor necrosis factor alpha; Immunology; Antibody","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002027055,0.0007190708,0.00229049,0.0003708495,0.0002840876,0.0001866243,0.0005968252,0.0008090948,0.02013538],"category_scores_gemma":[0.0006040867,0.0005594181,0.0008575875,0.0003698872,0.0003855248,0.0001112812,0.000226217,0.002594444,0.02266203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001311784,"about_ca_system_score_gemma":0.001022257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001277767,"about_ca_topic_score_gemma":0.00005485849,"domain_scores_codex":[0.9959813,0.0002741901,0.0008946624,0.0007330866,0.0009642298,0.001152574],"domain_scores_gemma":[0.9971653,0.0002795382,0.0002714326,0.001278129,0.0002563921,0.0007491924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006006864,0.0001622797,0.00003603962,0.00652715,0.0002782034,0.001621394,0.0001448106,4.815703e-9,0.00002270705,0.001840984,0.008117866,0.9811885],"study_design_scores_gemma":[0.001529578,0.0003386758,0.00003173193,0.01878274,0.00007129511,0.004424773,0.00005185412,0.00000723729,0.000009144558,0.0002221158,0.9740409,0.0004900077],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009764773,0.9630876,0.00001428582,0.001728264,0.001543472,0.001508995,0.0001047405,0.0001117537,0.0318032],"genre_scores_gemma":[0.001773554,0.97604,0.0001165582,0.00005610744,0.001322149,0.0001976619,0.0003041097,0.0001618082,0.02002804],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9806985,"threshold_uncertainty_score":0.9997066,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0343626504013133,"score_gpt":0.3351339835106432,"score_spread":0.3007713331093299,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}